SP-420 is under investigation in clinical trial NCT03801889 (SP-420 in Subjects With Transfusion-dependent Beta-thalassemia or Other Rare Anemias).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.